Resultados de la búsqueda 311-320 of 10112 for polycystic ovary syndrome
Departamentos y especialidades. Mayo Clinic tiene uno de los centros médicos más grandes y experimentados en los Estados Unidos, con sedes en Arizona, ...
... syndrome, and all-cause mortality 6 months after the event, and (2) improves stroke outcomes at 3 months in patients who experienced an ischemic stroke.
Patients will receive treatment until disease progression, unacceptable toxicity, consent withdrawal or death occurs. ... ovarian cancer, (7) advanced, ...
Science Saturday: Confronting polycystic kidney disease, a silent killer Aug. 12, 2023, 11:00 a.m. CDT. Productos y servicios. Boletín informativo: Mayo ...
Collection of tissue and blood from patients with residual disease after neoadjuvant systemic therapy for breast cancer. We hope to use these samples to find ...
A Study of Long-term Symptom Improvement and Recurrence After Operative Management of Median Arcuate Ligament Syndrome. Rochester, Minn. The purpose of this ...
This study aims to investigate the utility of using plasma DNA methylation to detect measurable residual disease or early recurrence/progression of patients ...
Autosomal Dominant Polycystic Kidney Disease: Early intervention and lifestyle crucial March 24, 2025, 06:23 p.m. CDT; Science Saturday: Confronting ...
The purpose of this study is to determine whether there is an increase in the time of a first occurrence of either: local recurrence, leptomeningeal disease ...
... disease with complete and long-term clinical follow-up to identify those who developed breast cancer (cases) and those who did not (controls); the ...
Mayo Clinic no respalda compañías ni productos. Las recaudaciones de los avisos comerciales financian nuestra misión sin fines de lucro.
Consulta estos éxitos de venta y ofertas especiales en libros y boletines informativos de Mayo Clinic Press.
¿Te gustaría hacer una donación deducible de impuestos y ser parte de una investigación de vanguardia y de una atención médica que transforma la medicina?